KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $6.9 million.

  • Medpace Holdings' Depreciation & Amortization (CF) fell 320.5% to $6.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $27.2 million, marking a year-over-year decrease of 218.64%. This contributed to the annual value of $27.2 million for FY2025, which is 218.64% down from last year.
  • Medpace Holdings' Depreciation & Amortization (CF) amounted to $6.9 million in Q4 2025, which was down 320.5% from $6.8 million recorded in Q3 2025.
  • Medpace Holdings' Depreciation & Amortization (CF)'s 5-year high stood at $7.2 million during Q3 2024, with a 5-year trough of $3.8 million in Q1 2021.
  • Over the past 5 years, Medpace Holdings' median Depreciation & Amortization (CF) value was $6.1 million (recorded in 2023), while the average stood at $5.7 million.
  • In the last 5 years, Medpace Holdings' Depreciation & Amortization (CF) skyrocketed by 5540.15% in 2021 and then crashed by 481.98% in 2025.
  • Quarter analysis of 5 years shows Medpace Holdings' Depreciation & Amortization (CF) stood at $4.2 million in 2021, then grew by 21.17% to $5.1 million in 2022, then increased by 26.62% to $6.4 million in 2023, then grew by 11.26% to $7.1 million in 2024, then dropped by 3.21% to $6.9 million in 2025.
  • Its last three reported values are $6.9 million in Q4 2025, $6.8 million for Q3 2025, and $6.8 million during Q2 2025.